1 document found, page 1 of 1

Sort by Issue Date
go first page go previous page
go to page: 1
go next page go last page
rss feed search results

Improving the identification of high-risk non-metastatic castration-resistant p...

Rosinha, A; Rabaça, C; Calais, F; Pinto, JM; Barreira, JV; Fernandes, R; Ramos, R; Fialho, AC; Palma dos Reis, J

Non-metastatic castration-resistant prostate cancer (nmCRPC) represents a challenging disease state in prostate cancer care. nmCRPC patients with a high risk of progression to metastatic disease who are identified by a prostate-specific antigen doubling time (PSADT) ≤10 months are eligible for treatment with the novel androgen receptor inhibitors (ARIs), shown to delay disease progression and extend survival. H...

Date: 2024   |   Origin: Saúde - CUF
More info.
go first page go previous page
go to page: 1
go next page go last page
rss feed search results

1 Results

Queried text

Refine Results

Author










Date


Document Type


Access rights


Resource


Subject